[EN] OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS<br/>[FR] OXADIAZOLONES EN TANT QU'INHIBITEURS DE CANAL POTENTIEL RÉCEPTEUR TRANSITOIRE
申请人:HOFFMANN LA ROCHE
公开号:WO2018096159A1
公开(公告)日:2018-05-31
The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
该发明涉及式(I)的化合物及其药用可接受的盐。此外,本发明涉及制备方法和使用式(I)的化合物的方法,以及含有这种化合物的药物组合物。这些化合物可能在治疗由TRPA1介导的疾病和症状,如疼痛方面有用。